115 related articles for article (PubMed ID: 33865993)
1. Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis.
Egebjerg K; Garbyal RS; Hasselby JP; Baeksgaard L; Mau-Sørensen M
Crit Rev Oncol Hematol; 2021 May; 161():103339. PubMed ID: 33865993
[TBL] [Abstract][Full Text] [Related]
2. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population.
Rong L; Wang B; Guo L; Liu X; Wang B; Ying J; Xue L; Lu N
Diagn Pathol; 2020 Mar; 15(1):27. PubMed ID: 32209107
[TBL] [Abstract][Full Text] [Related]
3. Concordance rate between HER2 immunohistochemistry and in situ hybridization in gastric carcinoma: systematic review and meta-analysis.
Pyo JS; Sohn JH; Kim WH
Int J Biol Markers; 2016 Feb; 31(1):e1-10. PubMed ID: 26349670
[TBL] [Abstract][Full Text] [Related]
4. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
5. HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis.
Egebjerg K; Harwood CD; Woller NC; Kristensen CA; Mau-Sørensen M
Front Oncol; 2021; 11():693394. PubMed ID: 34249747
[TBL] [Abstract][Full Text] [Related]
6. HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study.
Nagaraja V; Shaw N; Morey AL; Cox MR; Eslick GD
Eur J Surg Oncol; 2016 Jan; 42(1):140-8. PubMed ID: 26422587
[TBL] [Abstract][Full Text] [Related]
7. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
8. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa.
Brown J; Stepien AJ; Willem P
BMC Cancer; 2020 Apr; 20(1):281. PubMed ID: 32252688
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis.
Pyo JS; Kang G; Park K
Int J Biol Markers; 2016 Dec; 31(4):e389-e394. PubMed ID: 27102863
[TBL] [Abstract][Full Text] [Related]
10. Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.
van Rooijen JM; de Munck L; de Graaf JC; Siesling S; de Vries EG; Boers JE
Eur J Cancer; 2014 Mar; 50(5):885-91. PubMed ID: 24491395
[TBL] [Abstract][Full Text] [Related]
11. HER2 in situ hybridization in gastric and gastroesophageal adenocarcinoma: comparison of automated dual ISH to FISH.
Grin A; Brezden-Masley C; Bauer S; Streutker CJ
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):561-6. PubMed ID: 23455182
[TBL] [Abstract][Full Text] [Related]
12. HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.
Koopman T; van der Vegt B; Dijkstra M; Bart J; Duiker E; Wisman GBA; de Bock GH; Hollema H
Histopathology; 2018 Nov; 73(5):852-863. PubMed ID: 29989198
[TBL] [Abstract][Full Text] [Related]
13. What to expect from the 2018 ASCO/CAP HER2 guideline in the reflex in situ hybridization test of immunohistochemically equivocal 2+ cases?
Curado M; Caramelo AS; Eloy C; Polónia A
Virchows Arch; 2019 Sep; 475(3):303-311. PubMed ID: 30953146
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
Dominguez C; Rosa M; George TB; Pimiento J; Lauwers GY; Coppola D
Anticancer Res; 2018 Jan; 38(1):367-372. PubMed ID: 29277796
[TBL] [Abstract][Full Text] [Related]
15. Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
Thompson SK; Sullivan TR; Davies R; Ruszkiewicz AR
Ann Surg Oncol; 2011 Jul; 18(7):2010-7. PubMed ID: 21267790
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.
van Tilburg L; van de Ven SEM; Spaander MCW; van Kleef LA; Cornelissen R; Bruno MJ; Koch AD
J Cancer Res Clin Oncol; 2023 May; 149(5):1811-1823. PubMed ID: 35737094
[TBL] [Abstract][Full Text] [Related]
17. Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.
Ko YS; Kim NY; Pyo JS
Int J Biol Markers; 2018 Jan; 33(1):49-54. PubMed ID: 28478639
[TBL] [Abstract][Full Text] [Related]
18. Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection.
Kanaan C; Lorenzo D; Barret M; Audebourg A; Leblanc S; Chaussade S; Prat F; Terris B
Virchows Arch; 2020 Nov; 477(5):697-704. PubMed ID: 32524184
[TBL] [Abstract][Full Text] [Related]
19. Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma.
Takahashi M; Fukuda K; Saikawa Y; Nakamura R; Wada N; Kawakubo H; Takeuchi H; Kitagawa Y
Anticancer Res; 2020 Apr; 40(4):1921-1930. PubMed ID: 32234881
[TBL] [Abstract][Full Text] [Related]
20. New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.
Tchrakian N; Flanagan L; Harford J; Gannon JM; Quinn CM
Virchows Arch; 2016 Feb; 468(2):207-11. PubMed ID: 26521061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
